- New York City officials cut their forecast for the number of international tourists this year by 17%, saying President Donald Trump’s tariffs and hard-line policies on immigration are deterring visitors.
- World’s biggest carmaker’s forecast includes $1.25bn impact from trade levies in April and May
- House Republicans are considering nixing a Medicaid drug pricing plan floated by President Donald Trump and fiercely opposed by the pharmaceutical industry as the party pushes to strike a massive tax and spending deal in the coming days.
- A stampede of restructuring companies is creating a class system that's costing creditors billions. It’s a new blow for debt investors just as the economy needs them most.
- Vincent Clerc says changing supply chains fast using trade war is ‘very unrealistic’
- President Donald Trump spoke today on a trade deal with the U.K., the first such deal since his tariffs were announced. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
- A stampede of restructuring companies is creating a class system that's costing creditors billions. It’s a new blow for debt investors just as the economy needs them most.
- How the Oracle of Omaha embarrassed his own industry
- Companies with shortages of skilled workers look to shop class to recruit future hires; “like I’m an athlete getting all this attention from all these pro teams.”
- Entertainment group’s shares jump as it reports better than expected results
- The pharmaceutical industry estimates President Donald Trump’s new drug pricing proposal could cost drug companies as much as $1 trillion over a decade, its largest trade group is telling members of Congress.
- Trump’s tariffs were erratic and flawed but imbalances in the world economy are real
- China and others must think afresh as the US steps away from its role as balancer of last resort
- For the full experience visit: One Ship, $417 Million in New Tariffs: The Cost of Trump’s Trade War
- FDA Commissioner Marty Makary named Vinay Prasad, a hematologist oncologist and critic of the Covid-19 vaccine for children, as the next director of the Center for Biologics and Research.
- Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
- Private equity firms are taking the longest in more than a decade to give investors their money back. Elite college endowments, some of their most dependable clients, can’t wait much longer.
- The steep recovery in equity markets over the past two weeks is typical of bear market rallies, and the erratic swings mean almost every investor will experience pain whichever direction the market suddenly moves.
- China signaled that it’s not ready to let the yuan strengthen dramatically against the dollar, helping restore calm to Asia’s foreign-exchange market after days of extreme volatility.
- Currency surges as life insurers move to cover under-hedged positions in US assets
- Haddy employs eight robots that use artificial intelligence and machine learning to 3D-print furniture and other products with recycled materials.
- Levies on imports are giving early boosts to some American factories
- Saudi chemicals giant Sabic suffered a surprise loss in earnings for a second straight quarter, adding to signs the company is struggling to cope with market uncertainty and broad industry headwinds.
- The Oracle of Omaha always sought to do right by shareholders, and he wasn’t under the delusion that he was the only man for the job.
- Veteran investor says ‘trade should not be a weapon’ in dig at Donald Trump’s tariffs policy
- Florida’s housing boom has now shifted into reverse, with prices sliding by the most in at least 13 years.
- Private credit fund investors are offloading stakes at significant discounts ahead of more potential pain for the US economy, Oaktree Capital Management Co-Chief Executive Officer Robert O’Leary said.
- Trade tensions between the US and China are stalling agricultural commodity trader Bunge Global SA’s $8.2 billion takeover of Glencore Plc-backed Viterra, according to people familiar with the matter.
- Hospitals across the country are laying off staff and pausing payments to medical suppliers as they wait for millions in funding
- Wendy’s Co. lowered its sales outlook for this year, the latest restaurant chain to take a hit from consumer unease about shaky economic conditions in the US.
- Behind the scenes a new generation of more specialised agents is starting to take shape.
- Economic ‘pressures’ and consumer uncertainty over tariffs reduce traffic at burger chain’s restaurants
- The chart book available here looks at how US consumers and firms are responding to tariffs. For companies, new orders…
- Canadian pension fund Caisse de Dépôt et Placement du Québec is seeking to sell a Chicago office tower in a deal that’s expected to generate bids 59% lower than its last purchase price about eight years ago, according to a person familiar with the matter.
- Hiring at US companies moderated in April to the slowest pace in nine months, indicating waning demand for workers amid economic uncertainty.
- Archer-Daniels-Midland Co. is cutting jobs at its global commodity desk after a probe into its accounting practices wiped out billions from the agriculture giant’s value, according to people familiar with the matter.
- Trump’s unreliable America is throwing away the assets it needs
- A widely followed measure of Texas manufacturing activity weakened significantly as executives used words like “chaos” and “insanity” to describe the turmoil spurred by President Donald Trump’s tariffs, according to a report by the Federal Reserve Bank of Dallas.
- With several big solar companies in turmoil and tariffs that can change daily, choosing the right installer is crucial. Here’s what you need to know.
- Risky corporate-debt markets have room to drop further to reflect damage from the ongoing trade war, according to BlackRock Inc.
- Top policymakers seek to reassure public that economy can withstand worst of trade war
- A subscription to the Financial Times provides you with the insights and perspective you need to succeed, now.
- Searches for British courses surge following US president’s assault on Ivy League institutions, data shows
- Jerome Powell wins a reprieve. But expect more showdowns between the White House and the Fed
- He has already done lasting harm to America
- Cancellations accelerate; ‘shipments out of China for major retailers and manufacturers has ceased’
- Dissecting a dead-cat indicator
- Ad agencies adopt new strategies to ensure clients appear in results produced by OpenAI’s ChatGPT and Anthropic’s Claude